Investor’s pick: Oracle Corporation (NYSE:ORCL), Paragon Offshore plc (NYSE:PGN), Merrimack Pharmaceuticals (NASDAQ:MACK), Benchmark Electronics Inc. (NYSE:BHE), Crown Castle International Corp. (NYSE:CCI)


Oracle Corporation (NYSE:ORCL) reported Q2 EPS of $0.69, in-line with the analyst estimate of $0.69. Revenue for the quarter came in at $9.61 billion versus the consensus estimate of $9.5 billion. Cloud software-as-a-service (SaaS), platform-as-a-service (PaaS) and infrastructure-as-a-service (IaaS) revenue was up 45% to $516 million. Hardware Systems revenues were up 1% to $1.3 billion. The company sees Q3 adjusted EPS of $0.73 – $0.78, versus consensus estimates of $0.73. Oracle Corporation (NYSE:ORCL) in last trading activity moved up 1.30% to close at $41.16. Company weekly performance is 0.59% while its quarterly performance stands at -0.63%. Oracle Corporation (NYSE:ORCL) is -4.14% away from its 52 week high.

Paragon Offshore PLC (NYSE:PGN) Director J Robinson West purchased 10,500 shares of the stock on the open market in a transaction dated Friday, December 12th. The stock was purchased at an average cost of $2.95 per share, with a total value of $30,975.00. Following the completion of the acquisition, the director now directly owns 51,280 shares of the company’s stock, valued at approximately $151,276. On last trading day Paragon Offshore plc (NYSE:PGN) moved up 17.81% to close at $3.44. Its volatility for the week is 13.85% while volatility for the month is 10.47%. Paragon Offshore plc (NYSE:PGN) monthly performance is -30.92%.

Merrimack Pharmaceuticals (NASDAQ:MACK) SVP Edward J. Stewart unloaded 6,000 shares of the stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $10.63, for a total value of $63,780.00. Following the sale, the senior vice president now directly owns 21,385 shares in the company, valued at approximately $227,323. On last trading day Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) moved up 2.08% to close at $10.29. Its volatility for the week is 7.50% while volatility for the month is 6.17%. MACK’s sales growth for past 5 years was 160.30% and its EPS growth for past 5 years was -20.00%. Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) monthly performance is 19.37%.

Benchmark Electronics, Inc. (NYSE:BHE), a leading integrated contract manufacturing provider, announced on 8 December that its Board of Directors approved the repurchase of up to $100 million of the Company’s outstanding shares of common stock. Benchmark Electronics Inc. (NYSE:BHE) has 0.70% insider ownership while its institutional ownership stands at 96.40%. In last trading activity company’s stock closed at $24.25.

Crown Castle International Corp. (NYSE:CCI) has announced the completion of the previously announced merger with its former parent. Crown Castle completed the merger to facilitate its continued compliance with the rules governing real estate investment trusts by ensuring the effective adoption of certain charger provisions that implement ownership limitations and transfer restrictions related to its capital stock. On Wednesday shares of Crown Castle International Corp. (NYSE:CCI) closed at $75.11. Company’s sales growth for last 5 years was 14.60% and EPS growth for next 5 years is recorded as 61.25%.


Leave a Reply

Your email address will not be published. Required fields are marked *